<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04890678</url>
  </required_header>
  <id_info>
    <org_study_id>EC/2018/1291</org_study_id>
    <nct_id>NCT04890678</nct_id>
  </id_info>
  <brief_title>The Use of a Fully Automated Pulsating Support System (CuroCell® A4 CX20) in Pressure Ulcer Prevention and Treatment</brief_title>
  <official_title>The Use of a Fully Automated Pulsating Support System (CuroCell® A4 CX20) in Pressure Ulcer Prevention and Treatment: a Clinical Test in 10 Belgian Nursing Homes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Ghent</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Care of Sweden AB</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Ghent</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pressure Ulcers are a serious and common problem for residents admitted to long-term care&#xD;
      facilities and community care patients. They represent a major burden to patients, carers and&#xD;
      the Healthcare system, affecting approximately 1 in 20 community patients. International&#xD;
      guidelines recommend the use of pressure redistribution support surfaces, systematic patient&#xD;
      repositioning and preventive skin care to prevent pressure ulcers.&#xD;
&#xD;
      It has been acknowledged that a significant proportion of pressure ulcers are avoidable. The&#xD;
      prevalence of pressure ulcers is 1 of the 4 common harms recorded in the UK NHS Safety&#xD;
      Thermometer, a local improvement tool for measuring, monitoring and analyzing patient harms&#xD;
      across a range of settings, including nursing homes, community nursing and hospitals on a&#xD;
      monthly basis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 20, 2019</start_date>
  <completion_date type="Actual">October 30, 2019</completion_date>
  <primary_completion_date type="Actual">October 12, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pressure ulcer incidence</measure>
    <time_frame>30 days</time_frame>
    <description>Development of at least 1 Pressure ulcer category II+ during study period using European Pressure Ulcer Advisory Panel (EPUAP) classification system</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pressure ulcer healing</measure>
    <time_frame>30 days</time_frame>
    <description>Healing of pressure ulcers category III and IV during the 30-day study period - using the Pressure Ulcer Scale for Healing Tool (PUSH)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comfort</measure>
    <time_frame>30 days</time_frame>
    <description>perceived comfort and experiences of users of the mattress - using self-developed questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Pressure Ulcer</condition>
  <condition>Pressure Injury</condition>
  <condition>Pressure Sore</condition>
  <condition>Pressure Ulcer, Buttock</condition>
  <arm_group>
    <arm_group_label>22 residentsat risk for PU development</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>22 residents at risk for PU development, defined by a Braden score &lt; 12 and/or a Braden subscale 'Mobility' score ≤ 2 and/or the presence of non-blanchable erythema in the sacral area.&#xD;
aged 65 years or over</description>
  </arm_group>
  <arm_group>
    <arm_group_label>18 residents at least one PU category III-IV in the sacral area</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>18 residents at least one PU category III-IV in the sacral area aged 65 years or over</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>22 residentsat risk for PU development</intervention_name>
    <description>mattress in bed&#xD;
The presence of PUs will be evaluated using the European Pressure Ulcer Advisory Panel (EPUAP) classification system (NPUAP, 2014) and the presence of incontinence- associated dermatitis (IAD) will be categorized using the Ghent Global IAD Categorisation Tool (GLOBIAD). For each participant, the Patient Repositioning Tool Ghent (PROTECT) will be used to individually recommend the frequency of skin observations and the frequency of repositioning.</description>
    <arm_group_label>22 residentsat risk for PU development</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>18 residents at least one PU category III-IV in the sacral area</intervention_name>
    <description>mattress in bed The presence of PUs will be evaluated using the European Pressure Ulcer Advisory Panel (EPUAP) classification system (NPUAP, 2014) and the presence of incontinence- associated dermatitis (IAD) will be categorized using the Ghent Global IAD Categorisation Tool (GLOBIAD). For each participant, the Patient Repositioning Tool Ghent (PROTECT) will be used to individually recommend the frequency of skin observations and the frequency of repositioning.&#xD;
In the group of participants with a PU category III or IV, the Pressure Ulcer Scale for Healing Tool (PUSH) will be used to assess and measure change in PU status. The score on the PUSH-tool is defined by the surface area of the PU (length x width), the amount of exudate and the type of tissue in the wound bed.</description>
    <arm_group_label>18 residents at least one PU category III-IV in the sacral area</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  At risk of pressure ulcer development based on a Braden score ≤ 17 or pressure ulcer&#xD;
             category III or IV&#xD;
&#xD;
          -  Bedbound or chair bound&#xD;
&#xD;
          -  Aged ≥ 65&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Short-stay residents (expected length of stay ≤14 days)&#xD;
&#xD;
          -  End of life care&#xD;
&#xD;
          -  Medical contraindication for patient repositioning/turning&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>110 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dimitri Beeckman, Phd</last_name>
    <role>Principal Investigator</role>
    <affiliation>Study Principal Investigator</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>WZC Hof ter Waarbeek</name>
      <address>
        <city>Asse</city>
        <state>Vlaams-Brabant</state>
        <zip>1770</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <link>
    <url>https://www.skintghent.be/en</url>
    <description>Website of the research group</description>
  </link>
  <reference>
    <citation>Brown S, Smith IL, Brown JM, Hulme C, McGinnis E, Stubbs N, Nelson EA, Muir D, Rutherford C, Walker K, Henderson V, Wilson L, Gilberts R, Collier H, Fernandez C, Hartley S, Bhogal M, Coleman S, Nixon JE. Pressure RElieving Support SUrfaces: a Randomised Evaluation 2 (PRESSURE 2): study protocol for a randomised controlled trial. Trials. 2016 Dec 20;17(1):604.</citation>
    <PMID>27993145</PMID>
  </reference>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>May 5, 2021</study_first_submitted>
  <study_first_submitted_qc>May 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 18, 2021</study_first_posted>
  <last_update_submitted>May 17, 2021</last_update_submitted>
  <last_update_submitted_qc>May 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>support surface</keyword>
  <keyword>Elderly</keyword>
  <keyword>Nursing home</keyword>
  <keyword>prevention</keyword>
  <keyword>treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pressure Ulcer</mesh_term>
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Crush Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

